BIIB vs WOR · P/E 21, rev $9.89B vs P/E 34, rev $1.38B
Biogen Inc (BIIB) versus Worthington Industries Inc (WOR) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Worthington Industries Inc (WOR) is a metal fabrication company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported WOR revenue for 2026-05-31 was $1.38B. Net income was $156.1M. Revenue was up 19.7% from 2025-05-31 to 2026-05-31. WOR currently screens at market cap $3.26B and trailing P/E 34.0.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. WOR currently screens at market cap $3.26B and trailing P/E 34.0.
Not investment advice. Open the BIIB and WOR stock pages for the full models.
Not investment advice.